Clinical Trial: Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With Primary CNS Lymphoma

Brief Summary: This study suggests that R-IDARAM combined with intrathecal immunochemotherapy may be high effective in elderly patients with primary central nervous system lymphoma (PCNSL).

Detailed Summary: The investigators will evaluate response rate, progression free survival (PFS), overall survival (OS), and toxicity in elderly patients with primary central nervous system lymphoma (PCNSL) after systemic and intrathecal immunochemotherapy with deferred radiotherapy.
Sponsor: Navy General Hospital, Beijing

Current Primary Outcome: Overall survival [ Time Frame: 3year Overall survival ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Navy General Hospital, Beijing

Dates:
Date Received: July 14, 2016
Date Started: September 2010
Date Completion: December 2030
Last Updated: July 15, 2016
Last Verified: July 2016